Status:
COMPLETED
EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms
Lead Sponsor:
Cook Group Incorporated
Conditions:
Duodenal Obstruction
Gastric Outlet Obstruction
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this investigation is to compile clinical experience on the use of the Evolution® Duodenal Stent (Cook Ireland), a CE marked device intended for the palliative treatment of duodenal o...
Eligibility Criteria
Inclusion
- Patients for whom this device would be chosen in standard practice
Exclusion
- Patients for whom this device would not normally be chosen in standard practice
Key Trial Info
Start Date :
December 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00991614
Start Date
December 1 2009
End Date
March 1 2012
Last Update
March 29 2012
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Westmead Hospital
Sydney, Australia, 2145
2
Hopital Saint-Luc / CHUM
Montreal, Quebec, Canada, H2X3J4
3
Institution for Clinical and Experimental Medicine
Prague, Czechia
4
IRCCS Instituto Clinico Humanitas
Milan, Italy, 20089